A lymphoid leukemia characterized by a profound lymphocytosis with or without lymphadenopathy, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called t-cell chronic lymphocytic leukemia.
An aggressive t-cell leukemia, characterized by the proliferation of small to medium sized prolymphocytes with a mature t-cell phenotype, involving the blood, bone marrow, lymph nodes, liver, spleen, and skin. who, 2001)
C91.6 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2023 edition of ICD-10-CM C91.6 became effective on October 1, 2022.
This is the American ICD-10-CM version of C91.6 – other international versions of ICD-10 C91.6 may differ.